RXST
RxSight, Inc.
Medical Devices · Healthcare · United States
4.87
close · 2026-10-30
value
33
cheaper than peers33
quality
43
stronger fundamentals43
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 0.77× | 91 |
| price to sales | 1.59× | 67 |
| earnings yield, 1 year ago | -14.6% | 46 |
| cash flow yield, 1 year ago | -11.1% | 37 |
| earnings yield, latest year | -19.5% | 35 |
| cash flow yield, latest year | -9.5% | 34 |
| earnings yield, 2 years ago | -29.0% | 32 |
| earnings yield, 3 years ago | -49.5% | 27 |
| cash flow yield, 3 years ago | -30.2% | 25 |
| cash flow yield, 2 years ago | -22.9% | 22 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 4.0% | 90 |
| return on equity | -17.3% | 49 |
| revenue growth | 0.3% | 25 |
| operating margin | -40.8% | 24 |
4 of 4 measures available
Facts
| market cap | $203M |
| free cash flow | -$6.7M |
| employees | 461 |
| first trade | 2021-07-30 |
| next earnings | 2026-11-03 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.95 | -0.71 | -1.41 | -2.41 |
| free cash flow | -$19.3M | -$22.4M | -$46.4M | -$61.2M |
| net income | -$38.9M | -$27.5M | -$48.6M | -$66.8M |
| revenue | $134.5M | $139.9M | $89.1M | $49.0M |
| unusual items | $0 | $0 | -$1.8M | $0 |